PDGFRA and gastrointestinal stromal tumor: With the discovery of the common and mutually exclusive KIT or platelet-derived growth factor receptor alpha (PDGFRA) gain-of-function mutations, which occur in about 70%–80% and 7% of cases respectively, deeper insights on GIST biology have been progressively gained.